Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Childrens Cancer Group

Journal of Clinical Oncology

Volumn 12, Issue 11, 1994, Pages 2382-2389

  Matthay, Katherine K ^b   Seeger, Robert C ^b   Reynolds, C Patrick ^b   Stram, Daniel O ^b   O'Leary, Maura C ^b   Harris, Richard E ^b   Selch, Michael ^b   Atkinson, James B ^b   Haase, Gerald M ^b   Ramsay, Norma K ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0028151134     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.11.2382     Document Type: Article

References (28)

1. Brodeur GM, Castleberry RP: Neuroblastoma, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, Philadelphia, PA, Lippincott, 1993, pp 739-767
2. Seeger RC, Villabianca JG, Matthay KK et al: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 366:527-533, 1991
3. Graham-Pole J, Casper J, Elfenbein G, et al: High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:152-158, 1991 (published erratum in J Clin Oncol 9:1094, 1991)
4. Philip T, Zucker JM, Bernard JL, et al: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 9:1037-1044, 1991
5. Kushner BH, O'Reilly RJ, Mandell LR et al: Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9:274-279, 1991
6. Dini G, Lanino E, Garaventa A et al: Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: Report of 34 cases. J Clin Oncol 9:962-969, 1991
7. Seeger RC, Reynolds CP: Treatment of high risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 38:393-424, 1991
8. Glorieux P, Bouffet E, Philip I et al. Metastatic interstitial pneumonitis after autologous bone marrow transplantation: A consequence of reinjection of malignant cells? Cancer 1986; 58:2136-2139
9. Philip T, Zucker JM, et al: Bone marrow transplantation in an unselected group of 65 patients with stage IV neuroblastoma, in Dicke KA, Spitzer G, Jagannath S (eds): Autologous Marrow Transplantation: Proceedings of the Third International Symposium. Houston, TX, M.D. Anderson Hospital and Tumor Institute, 1987, pp 407-417
10. Moss TJ, Reynolds CP, Sather HN, et al: Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. N Engl J Med 324:219-226, 1991
11. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:374-378, 1971
12. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
13. Chatten J, Shimada H, Sather HN, et al: Prognostic value of histopathology in advanced neuroblastoma: A report from the Childrens Cancer Study Group. Hum Pathol 19:1187-1198, 1988
14. Hann HWL, Evans AE, Siegel SE, et al: Prognostic importance of serum ferritin in patients with stages III and IV neuroblastoma: The Childrens Cancer Study Group experience. Cancer Res 45:2843-2848, 1985
15. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
16. O'Leary MC, Sather HN, Ramsay NK, et al: Intensive chemotherapy for poor prognosis neuroblastoma. Proc Am Assoc Cancer Res 31:201, 1990 (abstr)
17. Brodeur GM, Seeger RC, Barrett A et al: International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6:1874-1881, 1988
18. Reynolds CP, Seeger RC, Vo DD et al: Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 46:5882-5886, 1986
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Matthay KK, Atkinson JB, Stram DO, et al: Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: A Childrens Cancer Group pilot study. J Clin Oncol 11:2226-2233, 1993
21. Seeger RC, Moss TJ, Feig SA, et al: Bone marrow transplantation for poor prognosis neuroblastoma. Prog Clin Biol Res 271:203-213, 1988
22. Dini G, Philip T, Hartmann O, et al: Bone marrow transplantation for neuroblastoma: A review of 509 cases. Bone Marrow Transplant 4:42-46, 1989 (suppl 4)
23. D'Angio GJ, August C, Elkins W, et al: Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution. Results of a four-institution Children's Cancer Study Group pilot study. Prog Clin Biol Res 175:557-563, 1985
24. Gorin NC: Collection, manipulation and freezing of haemopoietic stem cells. Clin Haematol 15:19-48, 1986
25. Herzig GP: Autologous marrow transplantation in cancer therapy, in Brown EB (ed) Progress in Hematology, vol 12. New York, NY, Grune & Stratton, 1981 pp 1-23
26. Sansone R, D, Martino D, Lanino E, et al: MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation. Bone Marrow Transplant 7:133-135, 1991 (suppl 3)
27. Stram DO, Matthay KK, O'Leary M, et al: Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma. Prog Clin Biol Res 385:287-291, 1994
28. Seeger RC, Matthay KK, Villablanca JG, et al: Intensive chemoradiotherapy and autologous bone marrow transplantation (ABMT) for high risk neuroblastoma. Proc Am Soc Clin Oncol 10:310, 1991 (abstr)